ADB-CHMINACA : Report on the risk assessment of N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances [PDF]
Language: Engels Series: Risk assessments ; 22Publication details: Lisbon EMCDDA 2018Description: 83 pSubject(s): Online resources:| Item type | Current library | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
E-bron
|
VAD | Not for loan |